Evidence map›Paper›PMID 34606495›Full record

Trial reportPLoS medicine2021

Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial.

Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis, Elizabeth C James, Carlos Diaz-Montana, William J Cragg, Conor Tweed, Archie Macnair, Matthew R Sydes, Claire Snowdon and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Engaging participants with research findings: A rights-informed approach.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Annabelle SouthMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0001-8912-2001
Nalinie Joharatnam-HoganMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0001-8406-2732
Cara PurvisMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0002-6093-4011
Elizabeth C JamesMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0002-0490-7211
Carlos Diaz-MontanaMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0001-9082-4596
William J CraggClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-1274-8521
Conor TweedMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0001-6021-8237
Archie MacnairMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.
Matthew R SydesMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0002-9323-1371
Claire SnowdonLondon School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-9133-5476
Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0001-7890-2854
Talia IsaacsUCL Institute of Education, University College London, London, United Kingdom.ORCID 0000-0003-4302-3379
Barbara E BiererHarvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0001-6448-8170
Andrew J CopasMRC CTU at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID 0000-0001-8968-5963

Funding

Cancer Research UK 12127Cancer Research UK 17092Cancer Research UK 26413Medical Research Council MC_UU_00004/08Medical Research Council MC_UU12023/24Medical Research Council MR/K025643/1
6 · The paper itself

Abstract

backgroundSharing trial results with participants is an ethical imperative but often does not happen. We tested an Enhanced Webpage versus a Basic Webpage, Mailed Printed Summary versus no Mailed Printed Summary, and Email List Invitation versus no Email List Invitation to see which approach resulted in the highest patient satisfaction with how the results were communicated. METHODS AND

findingsWe carried out a cluster randomised, 2 by 2 by 2 factorial, nonblinded study within a trial, with semistructured qualitative interviews with some patients (ISRCTN96189403). Each cluster was a UK hospital participating in the ICON8 ovarian cancer trial. Interventions were shared with 384 ICON8 participants who were alive and considered well enough to be contacted, at 43 hospitals. Hospitals were allocated to share results with participants through one of the 8 intervention combinations based on random permutation within blocks of 8, stratified by number of participants. All interventions contained a written plain English summary of the results. The Enhanced Webpage also contained a short video. Both the Enhanced Webpage and Email contained links to further information and support. The Mailed Printed Summary was opt-out. Follow-up questionnaires were sent 1 month after patients had been offered the interventions. Patients' reported satisfaction was measured using a 5-point scale, analysed by ordinal logistic regression estimating main effects for all 3 interventions, with random effects for site, restricted to those who reported receiving the results and assuming no interaction. Data collection took place in 2018 to 2019. Questionnaires were sent to 275/384 randomly selected participants and returned by 180: 90/142 allocated Basic Webpage, 90/133 Enhanced Webpage; 91/141 no Mailed Printed Summary, 89/134 Mailed Printed Summary; 82/129 no Email List Invitation, 98/146 Email List Invitation. Only 3 patients opted out of receiving the Mailed Printed Summary; no patients signed up to the email list. Patients' satisfaction was greater at sites allocated the Mailed Printed Summary, where 65/81 (80%) were quite or very satisfied compared to sites with no Mailed Printed Summary 39/64 (61%), ordinal odds ratio (OR) = 3.15 (1.66 to 5.98, p < 0.001). We found no effect on patient satisfaction from the Enhanced Webpage, OR = 1.47 (0.78 to 2.76, p = 0.235) or Email List Invitation, OR = 1.38 (0.72 to 2.63, p = 0.327). Interviewees described the results as interesting, important, and disappointing (the ICON8 trial found no benefit). Finding out the results made some feel their trial participation had been more worthwhile. Regardless of allocated group, patients who received results generally reported that the information was easy to understand and find, were glad and did not regret finding out the results. The main limitation of our study is the 65% response rate.

conclusionsNearly all respondents wanted to know the results and were glad to receive them. Adding an opt-out Mailed Printed Summary alongside a webpage yielded the highest reported satisfaction. This study provides evidence on how to share results with other similar trial populations. Further research is needed to look at different results scenarios and patient populations.

trial registrationISRCTN: ISRCTN96189403.

Indexed as

Information DisseminationAgedCluster AnalysisHealth CommunicationHumansInterviews as TopicMiddle AgedOutcome Assessment, Health CarePatient SatisfactionPatient Selection

Identifiers

PMID34606495
PMCPMC8523080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.